Covid-19HealthcareHow Self-Service RTSM Empowers CROs with Seamless Adaption Capabilities
Introduction In light of evolving regulatory requirements, recruitment challenges, and external factors such as the COVID-19 pandemic, clinical trials are becoming increasingly dynamic, resulting in more frequent protocol amendments and interactive response technology (IRT) reprogramming. A study by the Tufts Center for the Study of Drug Development published in 2024 found that over 75% of clinical trial protocols across Phases I-IV required at least one substantial amendment, with the average time to implement such an...